Comprehensive Perioperative Program Based on Prehabilitation, Nutritional Intervention and Psychological Support for Patients With Locally Advanced Operable Oesophagogastric Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMasaryk Memorial Cancer Institute

About this trial

Perioperative chemotherapy (CHT) or CHT/RT combined with surgery is the standard therapeutic approach for the treatment of locally advanced cancer of the esophagus, gastroesophageal junction (GEJ), and stomach. Comprehensive cancer treatment is associated with high perioperative morbidity and mortality. Serious postoperative complications occur in up to 20-80% of patients undergoing esophagectomy. The impact of nutritional status and overall physical condition on surgical outcomes and overall treatment has been demonstrated many times. The concept of pre-rehabilitation/pre-optimization, which involves establishing an individualized nutritional plan, monitoring and managing physical activity, and providing comprehensive supportive oncological and psychological care as early as during neoadjuvant CHT or CHT/RT, is a prerequisite for improving perioperative and 30-day postoperative morbidity and mortality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Consent to participate in the study

Age ≥ 18 years

Patients with locally advanced esophageal or gastric cancer indicated for comprehensive perioperative treatment

Resectable disease

Disqualifiers

Disseminated disease

Trial design

Design model

Single group

Treatments tested in this trial

  • Cardiorespiratory fitness (FsPS)

    Diagnostic test

    A single measurement before the start of preoperative treatment (baseline), after completion of chemotherapy 4-2 weeks before surgery, and 6 months after surgery.

  • Exercises you can do on your own at home

    Other intervention

    Exercise training is prescribed in accordance with the guidelines for prescribing physical activity (the FITT methodology published by the ACSM in 2018) for a period of 2 months. Training is set at 60% of the baseline maximum inspiratory pressure (MIP) and is increased by 5% if the participant reports a rate of perceived exertion (RPE) \< 7 (RPE scale 1-10). Exercises is conducted under supervision using telemedicine technologies. Weekly online check-ins via video call using the MOU MEDDI platform (first 4 weeks), then once every 14 days. Alternatively, weekly training sessions at the gym for the first 4 weeks (3 times a week at home, walking for at least 30 minutes per training session), followed by independent training at home. The intensity of aerobic training is prescribed based on a target heart rate of 60-80% of the heart rate reserve. An important part of the evaluation is also the patient's adherence to the exercise intervention and their level of physical activity.

  • Enhanced Recovery After Surgery ERAS

    Other intervention

    1. Preoperative evaluation in the Anesthesiology and Resuscitation Department (ARD)/Intensive Care Unit (ICU) and preoperative intensive care, assessment of the patient's condition, development of an anesthetic plan, and consultation with the patient and their family members. 2. Application of ERAS principles in the immediate preoperative period. 3. Application of ERAS principles intraoperatively. 4. Application of ERAS principles for the postoperative period. 5. Implementation of early detection of complications and their immediate resolution.

  • Nutritional support

    Other intervention

    1. Assessment of nutrition using the SGA (Seven-Point Subjective Global Assessment) 2. Assessment of nutritional status (nutritional requirements) using laboratory values, anthropometry, and bioimpedance 3. Assessment of weight loss or gain using selected parameters 4. Assessment of intake of regular food, oral dietary supplements, dietary modifications, and artificial nutrition

  • Psychological support

    Other intervention

    Psychological intervention is provided to each patient at the following time points: 1) upon enrollment in the study, 2) before surgery, 3) 30 days after surgery, and 4) 6 months after surgery.

  • Quality of life

    Other intervention

    It is assessed using standardized questionnaires.

  • Laboratory tests

    Diagnostic test

    Monitoring of cellular and humoral immunity/endocrine function will be performed by flow cytometry using two peripheral blood samples (1 tube containing 2.7 mL of EDTA-anticoagulated blood and 1 tube containing 5 mL of anticoagulant-free blood for serum separation) at 4 time points: 1) upon study enrollment, 2) before surgery, 3) 30 days after surgery, and 4) 6 months after surgery. Multicolor (6 to 8 colors) protocols for the proposed immune profile have already been established.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: InterventionalExperimental treatment 7 interventions

Trial outcomes

Primary outcomes

1

Change From Baseline in Autonomic Nervous System Balance as Measured by Heart Rate Variability

Evaluation of the root mean square of successive differences in milliseconds between heartbeats to assess parasympathetic activity.

Time frame
Baseline (pre-intervention), Perioperative, 1 year
2

Change From Baseline in Sleep Quality as Measured by the Pittsburgh Sleep Quality Index

Total score on the Pittsburgh Sleep Quality Index questionnaire (range 0-21), where higher scores indicate poorer sleep quality

Time frame
Baseline (pre-intervention), Perioperative, 1 year
3

Change From Baseline in Health-Related Quality of Life as Measured by the EORTC QLQ-C30 Questionnaire

Global health status/Quality of life scale score (range 0-100) from the European Organisation for Research and Treatment of Cancer core questionnaire

Time frame
Baseline (pre-intervention), Perioperative, 1 year
4

Change From Baseline in Fatigue Severity as Measured by the Functional Assessment of Chronic Illness Therapy - Fatigue Scale

Total score on the 13-item fatigue subscale (range 0-52), where lower scores indicate higher levels of fatigue.

Time frame
Baseline (pre-intervention), Perioperative, 1 year

Secondary outcomes

1

Incidence of Postoperative Respiratory Complications

Percentage of participants experiencing respiratory complications (e.g., pneumonia, respiratory failure) as defined by the Clavien-Dindo classification (Grade II or higher).

Time frame
Perioperative
2

Incidence of Anastomotic Dehiscence

Percentage of participants with radiologically or clinically confirmed leakage at the site of surgical anastomosis.

Time frame
Perioperative
3

Change From Baseline in Daily Physical Activity Level as Measured by Average Daily Step Count

Average number of steps per day recorded by a digital pedometer/accelerometer.

Time frame
Baseline (pre-intervention), Perioperative, 1 year
4

Change From Baseline in Lean Body Mass as Measured by Bioelectrical Impedance Analysis

Total lean body mass measured in kilograms (kg) using a multi-frequency Bioelectrical Impedance Analysis device.

Time frame
Baseline (pre-intervention), Perioperative, 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.